CRH Medical Corp (TSE:CRH) had its price objective decreased by analysts at Royal Bank Of Canada from C$6.00 to C$5.00 in a research report issued to clients and investors on Friday. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 59.24% from the company’s current price.

Several other analysts also recently weighed in on CRH. National Bank Financial lowered their price target on shares of CRH Medical Corp from C$7.00 to C$5.25 and set an “outperform” rating for the company in a research note on Friday. Scotiabank lowered their price target on shares of CRH Medical Corp from C$7.00 to C$6.75 and set an “outperform” rating for the company in a research note on Thursday. Bloom Burton downgraded shares of CRH Medical Corp from a “buy” rating to an “accumulate” rating in a research note on Friday, July 14th. Finally, TD Securities upped their price objective on shares of CRH Medical Corp from C$5.50 to C$10.00 and gave the company a “hold” rating in a research note on Tuesday, July 18th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of C$6.75.

CRH Medical Corp (TSE CRH) traded down 3.38% during mid-day trading on Friday, reaching $3.14. The company had a trading volume of 1,923,248 shares. The firm has a market capitalization of $232.11 million and a price-to-earnings ratio of 16.70. The firm has a 50-day moving average price of $6.16 and a 200 day moving average price of $8.46. CRH Medical Corp has a 12-month low of $3.10 and a 12-month high of $12.35.

COPYRIGHT VIOLATION WARNING: “CRH Medical Corp (CRH) PT Lowered to C$5.00 at Royal Bank Of Canada” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/08/06/crh-medical-corp-crh-pt-lowered-to-c5-00-at-royal-bank-of-canada.html.

In other news, Director David Johnson sold 30,000 shares of the company’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of C$5.67, for a total transaction of C$170,100.00.

About CRH Medical Corp

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (TSE:CRH)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.